Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphic Holding Inc (NQ: MORF ) 55.78 +0.03 (+0.05%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Morphic Holding Inc < Previous 1 2 3 Next > Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 December 08, 2021 Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... Via Benzinga CFO And COO Of Morphic Holding Trades $2.2M In Company Stock October 18, 2021 Marc Schegerin, CFO And COO at Morphic Holding (NASDAQ:MORF), made a large buy and sell of company shares on October 15, according to a new SEC filing. What Happened: A Form 4... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory The Past Week's Notable Insider Buys Include AppLovin, Cricut, Biotechs, And More August 21, 2021 With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week. Via Talk Markets The Past Week's Notable Insider Buys Included AppLovin, Cricut, Biotechs And More August 21, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window... Via Benzinga Morphic Therapeutic Shares New Positive MORF-057 Data From IBD Study July 09, 2021 Morphic Therapeutic (NASDAQ: MORF) has announced additional data from its Phase 1 trial evaluating MORF-057 for inflammatory bowel disease (IBD). The data... Via Benzinga The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision And Conference Presentations In A Light Week July 03, 2021 Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few COVID-19 disappointments,... Via Talk Markets Exposures COVID-19 Product Safety The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week July 03, 2021 Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO July 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... Via Benzinga The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test July 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... Via Benzinga Topics Product Recall Exposures COVID-19 Legal Product Safety Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, More May 29, 2021 Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near all-time highs. Some return buyers were among the insiders... Via Benzinga Is Morphic Holding a Buy? April 14, 2021 This experimental biotech has more than tripled investors' money over the past 12 months. Via The Motley Fool < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.